十一月 2025
- Home
- Rakuten Medical
十一月 2025的Rakuten Medical市场份额分析
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.
Rakuten Medical(包含公司地区分支机构)
查看更多网站流量和参与度信息- rakuten-med.com
Rakuten Medical收入截至 十一月 2025为 50M - 75M
Rakuten Medical主要域名产生的收入
3 年中Rakuten Medical主要域名的收入
Rakuten Medical主要域名的收入
Rakuten Medical热门域名的总访问量
了解Rakuten Medical市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Rakuten Medical热门域名的平均访问时长
分析Rakuten Medical参与度指标。
过去 3 个月的平均访问时长
子公司明细
Rakuten Medical热门域名的平均页面浏览量
了解Rakuten Medical如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Rakuten Medical 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Rakuten, Inc. attended event 40th Annual Meeting on Nov 10th '25.San Diego, CA - November 10, 2025 - Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox(TM) platform-based photoimmunotherapy, today announced that it presented new clinical data on its proprietary ASP-1929 photoimmunotherapy in a poster session at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2025), held November 5 - 9, 2025, in National Harbor, Maryland, USA.
十一月 10, 2025阅读更多
新闻Rakuten, Inc. hired Andrew Liu as Chief Financial Officer on Jun 23rd '25.San Diego, CA - Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox(TM) platform-based photoimmunotherapy, today announced that Andrew Liu has joined the Company as Chief Financial Officer (CFO).
六月 23, 2025阅读更多
查看 Rakuten Medical 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。